ANI Pharmaceuticals Inc (ANIP)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	415,063	287,529	286,000	294,618	290,109	284,975	252,174	216,472	177,600	146,725	123,446	111,196	115,526	121,207	126,420	127,884	121,318	118,777	122,251	133,201
Revenue (ttm)	US$ in thousands	614,376	555,456	538,953	517,460	486,816	449,394	401,386	358,694	316,385	283,082	251,322	226,092	216,136	212,459	213,377	213,222	208,475	199,189	197,547	203,434
Gross profit margin		67.56%	51.76%	53.07%	56.94%	59.59%	63.41%	62.83%	60.35%	56.13%	51.83%	49.12%	49.18%	53.45%	57.05%	59.25%	59.98%	58.19%	59.63%	61.88%	65.48%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $415,063K ÷ $614,376K
= 67.56%

The gross profit margin of ANI Pharmaceuticals Inc has shown fluctuations over the past few years. It started at a relatively high level of 65.48% as of March 31, 2020, then slightly decreased to 61.88% by June 30, 2020, and continued to decline to 53.45% by December 31, 2021. This downward trend reversed in the following periods, with an increase to 62.83% by June 30, 2023, and reaching a peak of 67.56% by December 31, 2024.

The fluctuations in ANI Pharmaceuticals Inc's gross profit margin may be indicative of changes in its cost structure, pricing strategies, or efficiency in managing production costs. It is essential for the company to monitor and analyze these fluctuations to ensure profitability and competitiveness in the market. Furthermore, a high gross profit margin indicates that the company is efficiently controlling its production costs and generating healthy profits from its core operations.